The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials

@inproceedings{Gu2016TheEA,
  title={The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials},
  author={Jianqiu Gu and Xin Meng and Yan Guo and Lei Wang and Hongzhi Zheng and Yixuan Liu and Bingshu Wu and Difei Wang},
  booktitle={Scientific reports},
  year={2016}
}
Liraglutide, a glucagon-like peptide (GLP-1) receptor agonist, has showed favorable effects in the glycaemic control and weight reduction in patients with type 2 diabetes mellitus (T2DM). The meta-analysis was to compare the efficacy and safety of liraglutide added to metformin with other treatments in patients with T2DM. A systematic literature search on PubMed, Embase, Web of Science and the Cochrane library databases were performed. Eligible studies were randomized controlled trials (RCTs… CONTINUE READING
BETA
1
Twitter Mention

Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review

L. Zhang, M. Zhang, Y. Zhang, N. Tong
  • Sci Rep
  • 2016

Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes

K Tanaka
  • Endocr J. 62,
  • 2015

Management of hyperglycemia in type 2 diabetes ,

S. E. Inzucchi
  • 2015

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

C Kapitza
  • Diabetes Obes Metab
  • 2013